[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Novartis AG Graphic](https://lunarcrush.com/gi/w:26/t:novartis.png) Novartis AG (NVS)

Novartis receives approval for the first malaria treatment for babies, while also facing generic competition for Entresto after a patent setback. The company's stock is up XXX% due to positive news.

### About Novartis AG
Novartis AG (NVS) is a pharmaceutical company.  
Novartis AG uses the ticker $NVS for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/novartis/insights)
- Novartis AG (NVS) trading volume is up XXXXXX% from the previous week.
- Novartis AG Price hit a high of XXXXXX for the hour
- Novartis AG Price hit an all time of XXXXXX for the hour

### Price: $XXXXXX [#](/topic/novartis/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:close.svg)  
[Price 24-Hour Chart Data](/topic/novartis/time-series/close.tsv)  
The current price increase of XXX% is likely influenced by positive news surrounding the approval of the new malaria treatment for babies, despite a recent patent setback.  

| 24-Hour | 7-Day  | 30-Day |
| ------- | -----  | ------ |
| -XXXX%  | -XXXX% | XXXX%  |

**1-Year High**: $XXXXXX on 2025-07-02  
**1-Year Low**: $XXXXX on 2024-12-19  
  
  
### AltRank: XXX [#](/topic/novartis/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:alt_rank.svg)  
[AltRank 24-Hour Chart Data](/topic/novartis/time-series/alt_rank.tsv)  
Novartis AG (NVS) is currently AltRank #878 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXX +106  
**1 Month**: XXX -XXX  
**6 Months**: XXX +51  
**1 Year**: XXX +73  
**1-Year High**: XXXXX on 2025-02-18  
**1-Year Low**: XX on 2024-07-28  
  
  
### Galaxy Score: XXXXX [#](/topic/novartis/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:galaxy_score.svg)  
[Galaxy Score 24-Hour Chart Data](/topic/novartis/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX +1  
**1 Month**: XX -XX  
**6 Months**: XX -X  
**1 Year**: XX +1  
**1-Year High**: XX on 2025-05-20  
**1-Year Low**: XX on 2024-10-20  
  
  
### Engagements: XXXXXXX [#](/topic/novartis/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/novartis/time-series/interactions.tsv)  
**Current Value**: XXXXXXX  
**Daily Average**: XXXXXXX  
**1 Week**: XXXXXXX -XX%  
**1 Month**: XXXXXXXXX -XX%  
**6 Months**: XXXXXXXXXX +41%  
**1 Year**: XXXXXXXXXX -XX%  
**1-Year High**: XXXXXXXXX on 2024-12-26  
**1-Year Low**: XXXXX on 2024-09-15  

| Social Network | X       | Reddit | YouTube | TikTok | News |
| -------------- | -       | ------ | ------- | ------ | ---- |
| Engagements    | XXXXXXX | XXX    | XXXXX   | XXXXX  | XXX  |
  

  
  
### Mentions: XXX [#](/topic/novartis/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/novartis/time-series/posts_active.tsv)  
**Current Value**: XXX  
**Daily Average**: XXX  
**1 Week**: XXX -XX%  
**1 Month**: XXXXX +7.50%  
**6 Months**: XXXXXX +145%  
**1 Year**: XXXXXX +86%  
**1-Year High**: XXX on 2025-04-11  
**1-Year Low**: XX on 2024-09-15  

| Social Network | X   | Reddit | YouTube | TikTok | News |
| -------------- | -   | ------ | ------- | ------ | ---- |
| Mentions       | XXX | XX     | XXX     | XX     | X    |
  

  
  
### Creators: XXX [#](/topic/novartis/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/novartis/time-series/contributors_active.tsv)  
XXX unique social accounts have posts mentioning Novartis AG (NVS) in the last XX hours which is up XX% from XXX in the previous XX hours
**Daily Average**: XXX  
**1 Week**: XXX -XX%  
**1 Month**: XXXXX +5.10%  
**6 Months**: XXXXX +129%  
**1 Year**: XXXXX +121%  
**1-Year High**: XXX on 2025-04-11  
**1-Year Low**: XX on 2024-09-15  

The most influential creators that mention Novartis AG in the last XX hours

| Creator                                          | Rank | Followers | Posts | Engagements |
| -------                                          | ---- | --------- | ----- | ----------- |
| [@ValueSense_io](/creator/twitter/ValueSense_io) | X    | XXXXXX    | X     | XXXXXX      |
| [@ReutersLegal](/creator/twitter/ReutersLegal)   | X    | XXXXXX    | X     | XXXXX       |
| [@novartis](/creator/youtube/novartis)           | X    | XXXXXX    | X     | XXX         |

[View More](/list/creators/novartis/100)
  
  
### Sentiment: XX% [#](/topic/novartis/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/novartis/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XX% -XX%  
**1 Month**: XX% -X%  
**6 Months**: XX% +3%  
**1 Year**: XX% +7%  
**1-Year High**: XXX% on 2024-08-24  
**1-Year Low**: XX% on 2024-08-13  

**Most Supportive Themes**
- **New Malaria Treatment Approval:** (50%) Novartis received Swiss approval for Coartem Baby, the first malaria treatment for newborns, generating significant positive engagement on social media.
- **Indian Origin CEO's:** (20%) Mentions of Novartis and its CEO being Indian-origin are trending positively across social media.
  
**Most Critical Themes**
- **Drug Trial Failure:** (4%)  A Novartis drug, Secukinumab, failed in a late-stage trial for treating blood vessel inflammation.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXXX   | XX% | XXXXXX  | XX% | XXXXX    | X% |
| Reddit  | XX       | X%  | XX      | X%  | X        | X% |
| YouTube | XXXXX    | X%  | XXXXX   | X%  | X        | X% |
| TikTok  | XXXXX    | X%  | XXXXX   | X%  | XXX      | X% |
| News    | XX       | X%  | XXX     | X%  | XX       | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXXX   | XX% | XXXXXX  | XX% | XXXXX    | X% |
  

  
  
### Social Dominance: XXXXX% [#](/topic/novartis/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:social_dominance.svg)  
[Social Dominance 24-Hour Chart Data](/topic/novartis/time-series/social_dominance.tsv)  
**Current Value**: XXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXX% -XXXXXXX%  
**1 Month**: XXXXX% -XXXXX%  
**6 Months**: XXXXX% +0.075%  
**1 Year**: XXXXX% +0.146%  
**1-Year High**: XXXXX% on 2025-04-11  
**1-Year Low**: XXXXX% on 2024-08-03  
  
  
### Market Dominance: XXXX% [#](/topic/novartis/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:market_dominance.svg)  
[Market Dominance 24-Hour Chart Data](/topic/novartis/time-series/market_dominance.tsv)  
**Current Value**: XXXX%  
**Daily Average**: X%  
**1-Year High**: XXXX% on 2025-03-31  
**1-Year Low**: XXXXX% on 2024-12-16  
  
  
### Market Cap: $XXXXXXXXXXXXXXX [#](/topic/novartis/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:novartis/c:line/m:market_cap.svg)  
[Market Cap 24-Hour Chart Data](/topic/novartis/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXXXX +$2.20%  
**1 Month**: $XXXXXXXXXXXXXXX +$6.40%  
**6 Months**: $XXXXXXXXXXXXXXX +$27%  
**1 Year**: $XXXXXXXXXXXXXXX +$11%  
**1-Year High**: $XXXXXXXXXXXXXXX on 2025-07-17  
**1-Year Low**: $XXXXXXXXXXXXXXX on 2024-12-19  

**Top assets mentioned**
In the posts about Novartis AG in the last XX hours

[Novartis AG (NVS)](/topic/$nvs)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[Alphabet Inc Class A (GOOGL)](/topic/$googl)
[Merck & Co., Inc. (MRK)](/topic/$mrk)
[Eli Lilly and Company (LLY)](/topic/eli-lilly)
[Amgen, Inc. (AMGN)](/topic/$amgn)
[Arcblock (ABT)](/topic/$abt)
[AbbVie Inc (ABBV)](/topic/$abbv)
[Microsoft Corp. (MSFT)](/topic/microsoft)

**Top topics mentioned**
In the posts about Novartis AG in the last XX hours

[$novnsw](/topic/$novnsw), [stocks healthcare](/topic/stocks-healthcare), [$nvs](/topic/$nvs), [babies](/topic/babies), [adobe](/topic/adobe), [youtube](/topic/youtube), [$pfe](/topic/$pfe), [india](/topic/india), [stocks technology](/topic/stocks-technology), [netapp](/topic/netapp), [stocks](/topic/stocks), [switzerland](/topic/switzerland), [coins healthcare](/topic/coins-healthcare), [$googl](/topic/$googl), [drugs](/topic/drugs), [investment](/topic/investment), [$novcde](/topic/$novcde), [$mrk](/topic/$mrk), [$baynsg](/topic/$baynsg), [eli lilly](/topic/eli-lilly), [tariffs](/topic/tariffs), [chanel](/topic/chanel), [money](/topic/money), [novo](/topic/novo), [#fyp](/topic/#fyp), [stocks communication services](/topic/stocks-communication-services), [$amgn](/topic/$amgn), [$abt](/topic/$abt), [acquisition](/topic/acquisition), [$abbv](/topic/$abbv), [bloomberg](/topic/bloomberg), [$novn](/topic/$novn), [sap](/topic/sap), [donald trump](/topic/donald-trump), [insurance](/topic/insurance), [microsoft](/topic/microsoft), [stx](/topic/stx), [$stx](/topic/$stx), [realdonaldtrump](/topic/realdonaldtrump), [coins ai](/topic/coins-ai), [careers](/topic/careers), [eli](/topic/eli), [$sdzsw](/topic/$sdzsw), [jpmorgan chase](/topic/jpmorgan-chase), [stocks financial services](/topic/stocks-financial-services), [women](/topic/women), [united states](/topic/united-states), [$lonnsw](/topic/$lonnsw), [sanofi](/topic/sanofi), [japan](/topic/japan), [jersey](/topic/jersey), [world of](/topic/world-of), [$galdsw](/topic/$galdsw), [$azn](/topic/$azn), [nasdaq](/topic/nasdaq), [hood](/topic/hood), [potus](/topic/potus), [wellness](/topic/wellness), [$pubpa](/topic/$pubpa), [cnbc](/topic/cnbc), [coins music](/topic/coins-music), [london](/topic/london), [manat](/topic/manat), [teva](/topic/teva), [transformative](/topic/transformative), [msft](/topic/msft), [$bmy](/topic/$bmy), [pep](/topic/pep), [ibkr](/topic/ibkr), [$mngl](/topic/$mngl), [super bowl](/topic/super-bowl), [uganda](/topic/uganda), [$vlvof](/topic/$vlvof), [volvo](/topic/volvo), [inflation](/topic/inflation), [$issc](/topic/$issc), [saving](/topic/saving), [$klac](/topic/$klac), [don t](/topic/don-t), [stockmarket](/topic/stockmarket), [coins analytics](/topic/coins-analytics), [$cop](/topic/$cop), [$10b](/topic/$10b), [Sentiment](/topic/sentiment), [$crm](/topic/$crm), [asml](/topic/asml), [$sap](/topic/$sap), [the worlds](/topic/the-worlds), [$lly](/topic/$lly), [stocks banks](/topic/stocks-banks), [$xbi](/topic/$xbi), [germany](/topic/germany), [$divislabbo](/topic/$divislabbo), [gabriel](/topic/gabriel), [debt](/topic/debt), [linkedin](/topic/linkedin), [spy](/topic/spy), [$dgpa](/topic/$dgpa), [greece](/topic/greece), [$alxn](/topic/$alxn)

### Top News [#](/topic/novartis/news)
---
Top news links shared on social in the last XX hours  

*Showing a maximum of X news posts for non-authenticated requests. Use your API key in requests for full results.*  

"Novartis Q2 profit rises XX% on strong U.S. sales of Kisqali and Entresto By Investing.com"  
[@Investingcom](/creator/x/Investingcom) on [X](/post/news/investing.com-465887787) 2025-07-17 05:31:51 UTC 1.3M followers, XX engagements


"Diabetic Macular Edema Pipeline 2025: MOA ROA FDA-Approved Drugs and Clinical Trial Progress Assessment by DelveInsight Oxurion Ocuphire Pharma YD Life Science Unity Biotechnology Novartis - The Globe and Mail"  
[@globeandmail](/creator/x/globeandmail) on [X](/post/news/theglobeandmail.com-2418283570) 2025-07-16 15:02:17 UTC 2M followers, XXX engagements



### Top Social Posts [#](/topic/novartis/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"💊 Novartis smashes Q2 expectations with $4.02B profit (vs. $3.72B est) up XX% YoY. 🚀 Boosts 2025 outlook & launches a $10B share buyback through 2027. CEO: Confidence in long-term growth. $NVS up XXX% YTD. #pharma #stocks"  
[@khalidshamim123](/creator/x/khalidshamim123) on [X](/post/tweet/1945736113609740416) 2025-07-17 06:43:34 UTC XXX followers, XX engagements


"Swiss pharma major Novartis announces a $XX billion share buyback. #Nifty #niftybank #Dow #SP500 #Nasdaq #zelena #Bitcoin #stocks #1 #"  
[@Niftyspeakloud](/creator/x/Niftyspeakloud) on [X](/post/tweet/1945735695727010076) 2025-07-17 06:41:54 UTC 1415 followers, XXX engagements


"Novartis $NVS $NOVN Q2 2025: Solid growth Net sales +12%; core operating income +20% with margins expanding to 42.2%. Free cash flow +37% to $6.3B. Kisqali (+64%) Scemblix (+79%) Leqvio (+61%) Kesimpta (+33%) Pluvicto (+30%). 🏆 Key updates: Positive Phase X readout for Pluvicto in prostate cancer. Accelerated FDA path for Vanrafia (IgAN) OAV101 (SMA) votoplam (Huntingtons) remibrutinib (food allergy). Share repurchase authorization up to $10B"  
[@TaxiBiotech](/creator/x/TaxiBiotech) on [X](/post/tweet/1945733276876108034) 2025-07-17 06:32:17 UTC XXX followers, XXX engagements


"@doepke_michel Agreed. Also Leqvio (what came out of The Medicines acquisition) now gearing towards blockbuster status and also showing a good growth. Novartis (via $NOVN ) remains my top non-bio position. A well-managed company"  
[@JoseRestonVA](/creator/x/JoseRestonVA) on [X](/post/tweet/1945731849306734903) 2025-07-17 06:26:37 UTC 2166 followers, XXX engagements